Postoperative management of patients with thoracic aorta diseases from the position of a cardiologist

Kozlov B.N.; Panfilov D.S.; Lelik E.V.; Chernykh Yu.N.

doi:https://doi.org/10.17116/kardio202215031242

Close metadata

Recommended articles:

Aortoiliac reconstruction with the quadrifurcated graft using robotics. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):561-565

Cryoballoon ablation combined with antiarrhythmic therapy for atrial fibrillation in patients with cardiovascular comorbidities. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):670-676

The influence of demographic factors and major comorbidities on serum circulating regulatory microRNAs in patients with coronary artery atherosclerosis and thoracic aortic aneurysm: a single-center cohort study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):174-182

Assessment of turbulent blood flow and wall shear stress in ascending aortic aneurysms. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):351-351

Step-by-step endovascular repair for thoracoabdominal aortic aneurysm. Pirogov Russian Journal of Surgery. 2024;(12-2):7-17

Post-Covid aortitis with cardiac involvement: progressive aortic aneurysm combined with active myocarditis. Russian Journal of Archive of Pathology. 2025;(2):53-58

Combination of gothic palate and pes cavus — pattern or coincidence?. Russian Journal of Stomatology. 2025;(3):74-80

Abstract:

The authors summarize the world experience in the treatment of patients after thoracic aortic repair. Management of patients after surgery for thoracic and thoracoabdominal aortic aneurysms and dissections is associated with a high rate of complications. It is currently one of important and unresolved issues in cardiology. Encouraging modern results of treatment allow us to outline a trend in solving this problem involving not only improvement of surgical treatment, but also an optimized approach to postoperative rehabilitation of these patients.

Keywords:

aorta

aortic aneurysm

connecting tissue dysplasia

aortic atherosclerosis

drug therapy

Authors:

Kozlov B.N.

Cardiology Research Institute of the Tomsk National Research Medical Center of the Russian Academy of Sciences

Panfilov D.S.

Tomsk National Research Medical Center

Lelik E.V.

Tomsk National Research Medical Center

Chernykh Yu.N.

Tomsk National Research Medical Center

Received:

16.04.2021

Accepted:

14.05.2021

Close metadata

References:

Norman PE, Fowkes GR, Aboyans V, et al. Global and regional burden of aortic dissection and aneurysms. Global Heart. 2014;8:171-180. https://doi.org/10.1093/med/9780198784906.003.0068_update_001
Sampson UKA, Norman PE, Fowkes GR, et al. Estimation of global and regional incidence and prevalence of ab-dominal aortic aneurysms 1990 to 2010. Global Heart. 2014;8:159-170. https://doi.org/10.1016/j.gheart.2013.12.009
Kozlov BN, Panfilov DS, Zherbakhanov AV, et al. Early results of various surgical approaches for ascending aortic aneurysms. Angiology and Vascular Surgery. 2019;25(3):101-106. (In Russ.). https://doi.org/10.33529/ANGIO2019310
Kozlov BN, Panfilov DS, Khodashinskiy IA. Five-year results of «frozen elephant trunk» procedure for thoracic aortic dissection. Angiology and Vascular Surgery. 2019;25(2):65-71. (In Russ.). https://doi.org/10.33529/ANGIO2019205
Feldman M, Shah M, Elefteriades JA. Medical management of acute type A aortic dissection. Ann Thorac Cardiovasc Surg. 2009;15(5):286-293.
Tran TP, Khoynezhad A. Current management of type B aortic dissection. Vascular Health and Risk Management. 2009;5:53-63. https://doi.org/10.2147/VHRM.S4205
Danyi P, Elefteriades JA, Jovin IS. Medical therapy of thoracic aortic aneurysms: are we there yet? Circulation. 2011;124:1469-1476. https://doi.org/10.1161/circulationaha.110.006486
Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010;121(13):266-369. https://doi.org/10.1161/CIR.0b013e3181d4739e
Saliba E, Sia Y, Dore A, el Hamamsy I. The ascending aortic aneurysm: when to intervene? IJC Heart & Vasculature. 2015;6:91-100. https://doi.org/10.1016/j.ijcha.2015.01.009
Erbel R, Aboyans V, Boileau C, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Kardiol Pol. 2014;72(12):1169-1252. https://doi.org/10.5603/KP.2014.0225
Groenink M, den Hartog AW, Franken R, et al. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: A randomized controlled trial. Eur Heart J. 2013;34(45):3491-3500. https://doi.org/10.1093/eurheartj/eht334
Ohte N, Narita H, Sugawara M, et al. Clinical usefulness of carotid arterial wave intensity in assessing left ventricular systolic and early diastolic performance. Heart Vessels. 2003;18(3):107-111. https://doi.org/10.1007/s00380-003-0700-5
Suzuki T, Isselbacher EM, Nienaber CA, et al. Type-selective benefits of medications in treatment of acute aortic dissection (from the international registry of acute aortic dissection [IRAD]). Am J Cardiol. 2012;109(1):122-127. https://doi.org/10.1016/j.jvs.2012.02.019
Brooke BS, Habashi JP, Judge DP, et al. Angiotensin II blockade and aortic-root dilation in Marfan’s syndrome. N Engl J Med. 2008;358:2787-2795. https://doi.org/10.1056/NEJMoa0706585
Williams A, Kenny D, Wilson D, et al. Effects of atenolol, perindopril and verapamil on haemodynamic and vascular function in Marfan syndrome — a randomised, double-blind, crossover trial. Eur J Clin Invest. 2012;42(8):891-899. https://doi.org/10.1111/j.1365-2362.2012.02668.x
Doyle JJ, Habashi JP, Lindsay ME, et al. Calcium channel blockers exacerbate aortic disease and cause premature lethality in Marfan syndrome. Circulation. 2010;122:A14647. https://doi.org/10.1159/000368539
Yang HH, Kim JM, Chum E, et al. Long-term effects of losartan on structure and function of the thoracic aorta in a mouse model of Marfan syndrome. Br J Pharmacol. 2009;158(6):1503-1512. https://doi.org/10.1111/j.1476-5381.2009.00443.x
Williams B, MacDonald TM, Morant S, et al. British Hypertension Society’s PATHWAY Studies Group. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): A randomised, double-blind, crossover trial. Lancet. 2015;386:2059-2068. https://doi.org/10.1016/S0140-6736(15)00257-3
Liu L, Xu B, Ju Y. Addition of spironolactone in patients with resistant hypertension: A meta-analysis of randomized controlled trials. Clin Exp Hypertens. 2017;39:257-263. https://doi.org/10.1080/10641963.2016.1246564
Wang C, Xiong B, Huang J. Efficacy and safety of spironolactone in patients with resistant hypertension: A meta-analysis of randomized controlled trials. Heart Lung Circ. 2016;25:1021-1030. https://doi.org/10.1016/j.hlc.2016.02.016
Thomopoulos C, Parati G, Zanchetti A. Effects of blood-pressure-lowering treatment on outcome incidence. Effects in individuals with high-normal and normal blood pressure: overview and meta-analyses of randomized trials. J Hypertens. 2017;35:2150-2160. https://doi.org/10.1097/HJH.0000000000001547
Beckett NS, Peters R, Fletcher AE, et al. HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-1898. https://doi.org/10.1056/NEJMoa0801369
de Bruin JL, Baas AF, Heymans MW, et al. Statin therapy is associated with improved survival after endovascular and open aneurysm repair. J Vasc Surg. 2014;59(1):39-44. https://doi.org/10.1016/j.jvs.2013.07.026
Goel SS, Tuzcu EM, Agarwal S, et al. Comparison of ascending aortic size in patients with severe bicuspid aortic valve stenosis treated with versus without a statin drug. Am J Cardiol. 2011;108(10):1458-1462. https://doi.org/10.1016/j.amjcard.2011.06.071
Nagashima H, Aoka Y, Sakomura Y, et al. A 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vasc Surg. 2012;36(1):158-163. https://doi.org/10.1067/mva.2002.123680
Loscalzo ML, Goh DL, Loeys B, et al. Familial thoracic aortic dilation and bicommissural aortic valve: A prospective analysis of natural history and inheritance. Am J Med Genet A. 2007;143A:1960-1967. https://doi.org/10.1002/ajmg.a.31872
Blackshear JL, Zabalgoitia M, Pennock G, et al. Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. SPAF TEE Investigators. Stroke Prevention and Atrial Fibrillation. Transesophageal echocardiography. Am J Cardiol. 1999;83:453-455. https://doi.org/10.1016/s0002-9149(98)00886-8
Dressler FA, Craig WR, Castello R, Labovitz AJ. Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol. 1998;31:134-138. https://doi.org/10.1016/S0735-1097(97)00449-X
Tunick PA, Nayar AC, Goodkin GM, et al. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol. 2002;90:1320-1325. https://doi.org/10.1016/S1062-1458(03)00057-6
Akselrod BA, Guskov DA, Charchyan ER, et al. Anesthetic support of aortic arch surgery: the nuances of organ protection. Anesthesiology and Reanimatology. 2015;(5):26-31. (In Russ.).
Belov YuV, Stepanenko AB, Kuznechevskiy FV. Immediate and long-term results of surgical treatment of ascending aortic and aortic arch aneurysms and dissections. Russian Journal of Cardiology. 2004;(5):5-16. (In Russ.). https://doi.org/10.15829/1560-4071-2004-5-5-16
Sievert DM, Rudrik JT, Patel JB, et al. Vancomycin-resistant Staphylococcus aureus in the United States. 2002—2006. Clin Infect Dis. 2008;46(5):668-674. https://doi.org/10.1086/527392
Sharpe JN, Shively EH, Polk HCJr. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. Am J Surg. 2005;189:425-428. https://doi.org/10.1016/j.amjsurg.2005.01.011
Weigelt J, Kaafarani HM, Itani KM, et al. Linezolid eradicates MRSA better than vancomycin from surgical-site infections. Am J Surg. 2004;188:760-766. https://doi.org/10.1016/j.amjsurg.2004.08.045
Finkelstein Y, Shemesh J, Mahlab K, et al. Colchicine for the prevention of postpericardiotomy syndrome. Herz. 2002;27:791-794. https://doi.org/10.1007/s00059-002-2376-5
Imazio M, Trinchero R, Brucato A, et al. Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS): A multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010;31:2749-2754. https://doi.org/10.1093/eurheartj/ehq319
Imazio M, Brucato A, Ferrazzi P, et al. Postpericardiotomy syndrome: A proposal for diagnostic criteria. J Cardiovasc Med (Hagerstown). 2013;14:351-353. https://doi.org/10.1016/S1062-1458(03)00057-6
Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36:2921-2964. https://doi.org/10.1093/eurheartj/ehv318
Ristic AD, Imazio M, Adler Y, et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2014;35:2279-2284. https://doi.org/10.1093/eurheartj/ehv318
Horneffer PJ, Miller RH, Pearson TA, et al. The effective treatment of postpericardiotomy syndrome after cardiac operations. A randomized placebo-controlled trial. J Thorac Cardiovasc Surg. 1990;100:292-296. https://doi.org/10.1016/S0022-5223(19)35571-0
Hagl C, Ergin MA, Galla JD, et al. Neurological outcome after ascending aorta — aortic arch operations: effect of brain protection on high3risk patients. J Thorac Cardiovasc Surg. 2001;1107-1121. https://doi.org/10.1067/mtc.2001.113179
Okita Y. Neuro-protection in open arch surgery. J Thorac Cardiovasc Surg. 2018;7(3):389-396. https://doi.org/10.21037/acs.2018.04.01
Zhivolupov SA, Bardakov SN, Samartsev IN, Gnevyshev EN. The role of anticholinesterase agents in optimizing the treatment of cerebrovascular diseases (theoretical background and clinical phenomenology). Korsakov Journal of Neurology and Psychiatry. Special issues. 2014;114(8-2):57-64. (In Russ.).
Arakelyan VS, Papitashvili VG, Zhane AK, Shchanitsyn IN. Prevention of perioperative complications in thoracolumbar aortic surgery. Kuban Scientific Medical Bulletin. 2013;4:21-28. (In Russ.).
Luneva EB, Malev EG, Pankova IA, Zemtsovsky EV. Drug therapy for thoracic aortic aneurysm. Arterial Hypertension 2018;24(3): 264-271. (In Russ.).